Cargando…

Surveillance Strategy after Curative Resection for Oesophageal Squamous Cell Cancer Using the Hazard Function

BACKGROUND: The optimal surveillance period and frequency after curative resection for oesophageal squamous cell carcinoma (OSCC) remain unclear, and current guidelines are mainly based on traditional Kaplan–Meier analyses of cumulative incidence rather than risk analysis. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanematsu, Kyohei, Kudose, Yozo, Utsunomiya, Daichi, Kubo, Kentaro, Fujii, Yusuke, Kurita, Daisuke, Ishiyama, Koshiro, Oguma, Junya, Daiko, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716854/
https://www.ncbi.nlm.nih.gov/pubmed/36457081
http://dx.doi.org/10.1186/s12885-022-10345-5
_version_ 1784842779029929984
author Kanematsu, Kyohei
Kudose, Yozo
Utsunomiya, Daichi
Kubo, Kentaro
Fujii, Yusuke
Kurita, Daisuke
Ishiyama, Koshiro
Oguma, Junya
Daiko, Hiroyuki
author_facet Kanematsu, Kyohei
Kudose, Yozo
Utsunomiya, Daichi
Kubo, Kentaro
Fujii, Yusuke
Kurita, Daisuke
Ishiyama, Koshiro
Oguma, Junya
Daiko, Hiroyuki
author_sort Kanematsu, Kyohei
collection PubMed
description BACKGROUND: The optimal surveillance period and frequency after curative resection for oesophageal squamous cell carcinoma (OSCC) remain unclear, and current guidelines are mainly based on traditional Kaplan–Meier analyses of cumulative incidence rather than risk analysis. The aim of this study was to determine a suitable follow-up surveillance program following oesophagectomy for OSCC using the hazard function. METHODS: A total of 1187 patients who underwent curative resection for OSCC between 2000 and 2014 were retrospectively analyzed. The changes in the estimated hazard rates (HRs) of recurrence over time were analyzed according to tumour-node-metastasis stage. RESULTS: Four hundred seventy-eight (40.2%) patients experienced recurrence during the follow-up period (median, 116.5 months). The risk of recurrence peaked at 9.2 months after treatment (HR = 0.0219) and then decreased to half the peak value at 24 months post-surgery. The HRs for Stage I and II patients were low (< 0.007) post-treatment. The HR for Stage III patients peaked at 9.9 months (HR = 0.031) and the hazard curve declined to a plateau at 30 months. Furthermore, the HR peaked at 10.8 months (HR = 0.052) in Stage IV patients and then gradually declined from 50 months. CONCLUSIONS: According to tumour-node-metastasis stage, changes in the HRs of postoperative recurrence in OSCC varied significantly. Intensive surveillance should be undertaken for 3 years in Stage III patients and for 4 years in Stage IV patients, followed by annual screening. For Stage I OSCC patients, a reduction in the surveillance intensity could be taken into consideration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10345-5.
format Online
Article
Text
id pubmed-9716854
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97168542022-12-03 Surveillance Strategy after Curative Resection for Oesophageal Squamous Cell Cancer Using the Hazard Function Kanematsu, Kyohei Kudose, Yozo Utsunomiya, Daichi Kubo, Kentaro Fujii, Yusuke Kurita, Daisuke Ishiyama, Koshiro Oguma, Junya Daiko, Hiroyuki BMC Cancer Research BACKGROUND: The optimal surveillance period and frequency after curative resection for oesophageal squamous cell carcinoma (OSCC) remain unclear, and current guidelines are mainly based on traditional Kaplan–Meier analyses of cumulative incidence rather than risk analysis. The aim of this study was to determine a suitable follow-up surveillance program following oesophagectomy for OSCC using the hazard function. METHODS: A total of 1187 patients who underwent curative resection for OSCC between 2000 and 2014 were retrospectively analyzed. The changes in the estimated hazard rates (HRs) of recurrence over time were analyzed according to tumour-node-metastasis stage. RESULTS: Four hundred seventy-eight (40.2%) patients experienced recurrence during the follow-up period (median, 116.5 months). The risk of recurrence peaked at 9.2 months after treatment (HR = 0.0219) and then decreased to half the peak value at 24 months post-surgery. The HRs for Stage I and II patients were low (< 0.007) post-treatment. The HR for Stage III patients peaked at 9.9 months (HR = 0.031) and the hazard curve declined to a plateau at 30 months. Furthermore, the HR peaked at 10.8 months (HR = 0.052) in Stage IV patients and then gradually declined from 50 months. CONCLUSIONS: According to tumour-node-metastasis stage, changes in the HRs of postoperative recurrence in OSCC varied significantly. Intensive surveillance should be undertaken for 3 years in Stage III patients and for 4 years in Stage IV patients, followed by annual screening. For Stage I OSCC patients, a reduction in the surveillance intensity could be taken into consideration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10345-5. BioMed Central 2022-12-01 /pmc/articles/PMC9716854/ /pubmed/36457081 http://dx.doi.org/10.1186/s12885-022-10345-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kanematsu, Kyohei
Kudose, Yozo
Utsunomiya, Daichi
Kubo, Kentaro
Fujii, Yusuke
Kurita, Daisuke
Ishiyama, Koshiro
Oguma, Junya
Daiko, Hiroyuki
Surveillance Strategy after Curative Resection for Oesophageal Squamous Cell Cancer Using the Hazard Function
title Surveillance Strategy after Curative Resection for Oesophageal Squamous Cell Cancer Using the Hazard Function
title_full Surveillance Strategy after Curative Resection for Oesophageal Squamous Cell Cancer Using the Hazard Function
title_fullStr Surveillance Strategy after Curative Resection for Oesophageal Squamous Cell Cancer Using the Hazard Function
title_full_unstemmed Surveillance Strategy after Curative Resection for Oesophageal Squamous Cell Cancer Using the Hazard Function
title_short Surveillance Strategy after Curative Resection for Oesophageal Squamous Cell Cancer Using the Hazard Function
title_sort surveillance strategy after curative resection for oesophageal squamous cell cancer using the hazard function
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716854/
https://www.ncbi.nlm.nih.gov/pubmed/36457081
http://dx.doi.org/10.1186/s12885-022-10345-5
work_keys_str_mv AT kanematsukyohei surveillancestrategyaftercurativeresectionforoesophagealsquamouscellcancerusingthehazardfunction
AT kudoseyozo surveillancestrategyaftercurativeresectionforoesophagealsquamouscellcancerusingthehazardfunction
AT utsunomiyadaichi surveillancestrategyaftercurativeresectionforoesophagealsquamouscellcancerusingthehazardfunction
AT kubokentaro surveillancestrategyaftercurativeresectionforoesophagealsquamouscellcancerusingthehazardfunction
AT fujiiyusuke surveillancestrategyaftercurativeresectionforoesophagealsquamouscellcancerusingthehazardfunction
AT kuritadaisuke surveillancestrategyaftercurativeresectionforoesophagealsquamouscellcancerusingthehazardfunction
AT ishiyamakoshiro surveillancestrategyaftercurativeresectionforoesophagealsquamouscellcancerusingthehazardfunction
AT ogumajunya surveillancestrategyaftercurativeresectionforoesophagealsquamouscellcancerusingthehazardfunction
AT daikohiroyuki surveillancestrategyaftercurativeresectionforoesophagealsquamouscellcancerusingthehazardfunction